Stories

Prime Therapeutics lands No. 3 spot on Minneapolis/St. Paul Business Journal’s 2020 Top 100 Private Companies List

Prime ranked third-largest in state by revenue

September 4, 2020

For a third consecutive year, The Minneapolis/St. Paul Business Journal placed Prime at No. 3 on its 2020 Top 100 Private Companies List. Once again, Prime shares the top three with Cargill and CHS.

The annual list ranks companies by revenue. To qualify for the ranking, a company must have headquarters in Minnesota, be a for-profit operation and not issue stock to the public.

The full Top 100 Private Companies List is available now online and will publish in the Minneapolis/St. Paul Business Journal’s annual Book of Lists later this year.

About Prime Therapeutics

Prime Therapeutics LLC (Prime) helps people get the medicine they need to feel better and live well. Prime provides total drug management solutions for health plans, employers, and government programs including Medicare and Medicaid. The company processes claims and offers clinical services for people with complex medical conditions. Prime serves nearly 33 million people. It is collectively owned by 19 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those plans.

Related news

Stories

November 16, 2021

30 Prime-supported Medicare contracts earn quality bonuses

Prime Therapeutics (Prime) helped 30 of its Medicare Advantage Prescription Drug (MAPD) contracts,…

Read More

Stories

November 16, 2021

Prime Therapeutics launches IntegratedRx – Oncology, partners on MIP Accreditation

by Angela Maas As published in AIS’s Radar on Specialty Pharmacy (Content reprinted…

Read More

Stories

November 14, 2021

International Fraud Awareness Week: Prime’s five efforts to fight fraud

Although International Fraud Awareness Week is a dedicated seven days to encourage organizations…

Read More
View all news